论文部分内容阅读
目的:探究并分析布地奈德联合盐酸氨溴索雾化吸入对于治疗小儿支气管肺炎的临床疗效。方法:现选择入住我院儿科病房小儿支气管肺炎患儿60例,平均分为两组,联合治疗组和单一治疗组,每组30人。给予联合治疗组30例患儿以布地奈德联合盐酸氨溴索雾化吸入治疗;给予单一治疗组30例患儿以布地奈德单一治疗。两组患儿均在进行相同常规治疗外,采取以上不同治疗方案进行治疗。治疗后,观察患儿的临床治疗效果,并加以统计评价。结果:治疗一周后观察两组患儿治疗效果。联合治疗组相对有效率为93.33%;而单一治疗组相对有效率为83.33%。两组数据相比,联合治疗组的相对有效率明显高于单一治疗组。在咳嗽、气促及肺部X线片阴影消失时间方面,联合治疗组亦均优于单一治疗组,且P<0.05,差异具有统计学意义。结论:布地奈德联合盐酸氨溴索雾化吸入治疗小儿支气管肺炎疗效显著,值得选择。
Objective: To investigate and analyze the clinical efficacy of budesonide combined with inhalation of ambroxol hydrochloride in the treatment of bronchial pneumonia in children. Methods: Now choose to stay in our hospital pediatric ward children with bronchial pneumonia in 60 cases, divided into two groups, the combined treatment group and a single treatment group, 30 in each group. Thirty children were given combination therapy with budesonide and ambroxol hydrochloride. Thirty children with single treatment group were treated with budesonide alone. Two groups of children were in the same routine treatment, to take more than the different treatment options for treatment. After treatment, observe the clinical effect of treatment in children and make statistical evaluation. Results: One week after treatment, the therapeutic effects of two groups of children were observed. The relative effective rate in combination therapy group was 93.33%, while the relative effective rate in single therapy group was 83.33%. Compared to the two groups, the relative efficacy of the combination therapy group was significantly higher than that of the single therapy group. In the cough, shortness of breath and shadow disappearance of the lung radiographs, the combination therapy group were also superior to the single treatment group, and P <0.05, the difference was statistically significant. Conclusion: The efficacy of budesonide combined with ambroxol hydrochloride inhalation in the treatment of children with bronchopneumonia is significant and worthy of choice.